Antitrust Antitrust

Public officials to blame for outsized power of prescription drug middlemen, US FTC’s Khan says

By Michael Acton
  • 22 Jun 2022 20:19
  • 22 Jun 2022 20:19
Consumers suffering from higher prescription drug costs due to powerful middlemen who sit between drug manufacturers and pharmacies can blame years of bad decisions by public officials, US Federal Trade Commission Chair Lina Khan said today.

“All of these features of our current system are the result of policy choices and legal decisions

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News